HRP970699A2 - Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms - Google Patents

Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms

Info

Publication number: HRP970699A2
Authority: HR; Croatia
Prior art keywords: crystallisation; crystalline forms; resulting crystalline; tetrahydropyridin; derivative
Prior art date: 1996-12-23

Application number

HR9615904A

Inventor

Olivier Monnier

Original Assignee

Olivier Monnier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-23

Filing date

1997-12-22

Publication date

1998-10-31

1997-12-22 Application filed by Olivier Monnier filed Critical Olivier Monnier

1998-10-31 Publication of HRP970699A2 publication Critical patent/HRP970699A2/en

2007-03-31 Publication of HRP970699B1 publication Critical patent/HRP970699B1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HR970699A 1996-12-23 1997-12-22 Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms HRP970699B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9615904A FR2757543B1 (en)	1996-12-23	1996-12-23	PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

Publications (2)

Publication Number	Publication Date
HRP970699A2 true HRP970699A2 (en)	1998-10-31
HRP970699B1 HRP970699B1 (en)	2007-03-31

Family

ID=9499043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR970699A HRP970699B1 (en)	1996-12-23	1997-12-22	Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms

Country Status (38)

Country	Link
EP (1)	EP0950050B1 (en)
JP (2)	JP4499188B2 (en)
KR (1)	KR100586670B1 (en)
CN (1)	CN1129580C (en)
AR (1)	AR009672A1 (en)
AT (1)	ATE307802T1 (en)
AU (1)	AU736697B2 (en)
BR (1)	BR9714081A (en)
CA (1)	CA2275596C (en)
CO (1)	CO5070688A1 (en)
CZ (1)	CZ296689B6 (en)
DE (1)	DE69734460T2 (en)
DK (1)	DK0950050T3 (en)
DZ (1)	DZ2383A1 (en)
EE (1)	EE04188B1 (en)
EG (1)	EG21567A (en)
ES (1)	ES2251038T3 (en)
FR (1)	FR2757543B1 (en)
HR (1)	HRP970699B1 (en)
HU (1)	HU227425B1 (en)
IL (1)	IL129938A (en)
IN (1)	IN186976B (en)
IS (1)	IS2357B (en)
MY (1)	MY118015A (en)
NO (1)	NO312364B1 (en)
NZ (1)	NZ336130A (en)
PL (1)	PL190494B1 (en)
RS (1)	RS49882B (en)
RU (1)	RU2192416C2 (en)
SA (1)	SA98180971B1 (en)
SI (1)	SI0950050T1 (en)
SK (1)	SK285088B6 (en)
TR (1)	TR199901363T2 (en)
TW (1)	TW518322B (en)
UA (1)	UA60324C2 (en)
UY (1)	UY24825A1 (en)
WO (1)	WO1998028271A1 (en)
ZA (1)	ZA9711576B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2757543B1 (en) *	1996-12-23	1999-04-02	Sanofi Sa	PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED
FR2782082B3 (en) *	1998-08-05	2000-09-22	Sanofi Sa	CRYSTALLINE FORMS OF (R) - (+) - N - [[3- [1-BENZOYL-3- (3,4- DICHLOROPHENYL) PIPERIDIN-3-YL] PROP-1-YL] -4-PHENYLPIPERIDIN-4 - YL] -N-METHYLACETAMIDE (OSANETANT) AND PROCESS FOR THE PREPARATION OF SAID COMPOUND
JP5504334B2 (en)	2010-03-12	2014-05-28	株式会社日本触媒	Method for producing water absorbent resin
EP2643294B1 (en) *	2011-04-15	2016-08-24	Emcure Pharmaceuticals Limited	An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2531707A1 (en) *	1982-08-16	1984-02-17	Midy Spa	SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES WITH ANOREXIGENIC ACTIVITY, A PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS
FR2757543B1 (en) *	1996-12-23	1999-04-02	Sanofi Sa	PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

1996
- 1996-12-23 FR FR9615904A patent/FR2757543B1/en not_active Expired - Fee Related
1997
- 1997-12-19 AR ARP970106029A patent/AR009672A1/en not_active Application Discontinuation
- 1997-12-22 HR HR970699A patent/HRP970699B1/en not_active IP Right Cessation
- 1997-12-22 MY MYPI97006233A patent/MY118015A/en unknown
- 1997-12-22 DZ DZ970233A patent/DZ2383A1/en active
- 1997-12-23 NZ NZ336130A patent/NZ336130A/en not_active IP Right Cessation
- 1997-12-23 IL IL12993897A patent/IL129938A/en not_active IP Right Cessation
- 1997-12-23 EG EG138397A patent/EG21567A/en active
- 1997-12-23 HU HU0001387A patent/HU227425B1/en not_active IP Right Cessation
- 1997-12-23 IN IN3761DE1997 patent/IN186976B/en unknown
- 1997-12-23 AT AT97952986T patent/ATE307802T1/en active
- 1997-12-23 RS YUP-289/99A patent/RS49882B/en unknown
- 1997-12-23 DK DK97952986T patent/DK0950050T3/en active
- 1997-12-23 TR TR1999/01363T patent/TR199901363T2/en unknown
- 1997-12-23 UA UA99063521A patent/UA60324C2/en unknown
- 1997-12-23 SK SK828-99A patent/SK285088B6/en not_active IP Right Cessation
- 1997-12-23 JP JP52848198A patent/JP4499188B2/en not_active Expired - Fee Related
- 1997-12-23 WO PCT/FR1997/002393 patent/WO1998028271A1/en not_active Ceased
- 1997-12-23 CO CO97074792A patent/CO5070688A1/en unknown
- 1997-12-23 PL PL97334256A patent/PL190494B1/en not_active IP Right Cessation
- 1997-12-23 BR BR9714081-3A patent/BR9714081A/en not_active Application Discontinuation
- 1997-12-23 RU RU99116597/04A patent/RU2192416C2/en not_active IP Right Cessation
- 1997-12-23 CA CA002275596A patent/CA2275596C/en not_active Expired - Fee Related
- 1997-12-23 ZA ZA9711576A patent/ZA9711576B/en unknown
- 1997-12-23 SI SI9730720T patent/SI0950050T1/en unknown
- 1997-12-23 KR KR1019997005373A patent/KR100586670B1/en not_active Expired - Fee Related
- 1997-12-23 ES ES97952986T patent/ES2251038T3/en not_active Expired - Lifetime
- 1997-12-23 AU AU56684/98A patent/AU736697B2/en not_active Ceased
- 1997-12-23 EE EEP199900264A patent/EE04188B1/en not_active IP Right Cessation
- 1997-12-23 CN CN97180863A patent/CN1129580C/en not_active Expired - Fee Related
- 1997-12-23 EP EP97952986A patent/EP0950050B1/en not_active Expired - Lifetime
- 1997-12-23 CZ CZ0229299A patent/CZ296689B6/en not_active IP Right Cessation
- 1997-12-23 UY UY24825A patent/UY24825A1/en not_active IP Right Cessation
- 1997-12-23 DE DE69734460T patent/DE69734460T2/en not_active Expired - Lifetime
1998
- 1998-01-21 TW TW086119629A patent/TW518322B/en not_active IP Right Cessation
- 1998-03-11 SA SA98180971A patent/SA98180971B1/en unknown
1999
- 1999-06-10 IS IS5076A patent/IS2357B/en unknown
- 1999-06-22 NO NO19993076A patent/NO312364B1/en not_active IP Right Cessation
2009
- 2009-05-07 JP JP2009112971A patent/JP2009197022A/en active Pending

Also Published As

Publication number	Publication date
SK82899A3 (en)	1999-12-10
RS49882B (en)	2008-08-07
UA60324C2 (en)	2003-10-15
FR2757543A1 (en)	1998-06-26
KR100586670B1 (en)	2006-06-07
WO1998028271A1 (en)	1998-07-02
EE04188B1 (en)	2003-12-15
FR2757543B1 (en)	1999-04-02
UY24825A1 (en)	1998-04-21
ES2251038T3 (en)	2006-04-16
TR199901363T2 (en)	1999-08-23
EE9900264A (en)	2000-02-15
SK285088B6 (en)	2006-06-01
JP2009197022A (en)	2009-09-03
NO993076D0 (en)	1999-06-22
MY118015A (en)	2004-08-30
IL129938A (en)	2004-06-20
TW518322B (en)	2003-01-21
JP2001507012A (en)	2001-05-29
HU227425B1 (en)	2011-05-30
JP4499188B2 (en)	2010-07-07
AR009672A1 (en)	2000-04-26
ATE307802T1 (en)	2005-11-15
SI0950050T1 (en)	2006-04-30
IL129938A0 (en)	2000-02-29
NO312364B1 (en)	2002-04-29
CA2275596A1 (en)	1998-07-02
YU28999A (en)	2003-01-31
CN1129580C (en)	2003-12-03
IS5076A (en)	1999-06-10
IS2357B (en)	2008-04-15
CA2275596C (en)	2005-10-11
NO993076L (en)	1999-06-22
NZ336130A (en)	2001-01-26
AU736697B2 (en)	2001-08-02
SA98180971B1 (en)	2006-09-13
KR20000069504A (en)	2000-11-25
CO5070688A1 (en)	2001-08-28
DZ2383A1 (en)	2002-12-28
EP0950050B1 (en)	2005-10-26
PL190494B1 (en)	2005-12-30
HUP0001387A2 (en)	2000-09-28
DE69734460T2 (en)	2006-07-06
HK1024002A1 (en)	2000-09-29
BR9714081A (en)	2000-05-09
ZA9711576B (en)	1998-06-25
DE69734460D1 (en)	2005-12-01
CZ296689B6 (en)	2006-05-17
EP0950050A1 (en)	1999-10-20
EG21567A (en)	2001-12-31
DK0950050T3 (en)	2006-01-23
HUP0001387A3 (en)	2002-03-28
CN1241180A (en)	2000-01-12
PL334256A1 (en)	2000-02-14
AU5668498A (en)	1998-07-17
CZ229299A3 (en)	1999-09-15
IN186976B (en)	2001-12-22
HRP970699B1 (en)	2007-03-31
RU2192416C2 (en)	2002-11-10

Legal Events

Date	Code	Title	Description
1998-10-31	A1OB	Publication of a patent application
1999-04-28	AIPI	Request for the grant of a patent on the basis of a substantive examination of a patent application
2000-07-12	PPPP	Transfer of rights	Owner name: SANOFI-SYNTHELABO, FR
2005-02-17	PNAN	Change of the applicant name, address/residence	Owner name: SANOFI-AVENTIS, FR
2007-03-31	B1PR	Patent granted
2011-12-17	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20111217 Year of fee payment: 15
2013-06-23	PBON	Lapse due to non-payment of renewal fee	Effective date: 20121223

Publication	Publication Date	Title
PL322501A1 (en)	1998-02-02	Method of obtaining 2-methyl-thiene-bezodiazepin and crystalline forms thereof
HUP9903454A3 (en)	2001-04-28	A crystalline form of cefditoren pivoxyl and process for the production of the same
HUP9601857A3 (en)	1998-07-28	N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
HUT64347A (en)	1993-12-28	Method for producing alkyl-diammonium-diclavulanate derivatives
HUP9700536A3 (en)	1999-01-28	Crystalline vitamin d derivative
HUP9603377A2 (en)	1997-08-28	Crystalline maltitol composition and method for preparing the same
HUT74163A (en)	1996-11-28	New crystalline cepheme-acid-addicional salts and process for producing them
HU9302108D0 (en)	1993-10-28	Method for producing physostigmine-carbamate derivatives
SI0950050T1 (en)	2006-04-30	Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms
AU2567897A (en)	1997-10-29	Method and means for the production of a spring insert
AU5655698A (en)	1998-07-03	Suspension crystallization method
AU2274797A (en)	1997-10-01	Crystalline protease and method for producing same
ZA989780B (en)	1999-04-28	Novel crystal of depsipeptide derivative and a method for producing the same
IL130205A0 (en)	2000-06-01	Method for producing 1-phenyl-uracil derivatives
HU9302277D0 (en)	1993-10-28	Method for producing imidazo-pyridine derivatives
AU5655798A (en)	1998-07-03	Suspension crystallization method
GB9700086D0 (en)	1997-02-19	Method for producing ceramic superconductor single crystals
GB2319772B (en)	2000-11-08	2-phenylazulene derivatives and a manufacturing method of these compounds
GB9621935D0 (en)	1996-12-18	Method for the control of crystallization
PL318306A1 (en)	1998-08-17	Method of obtaining crystalline cephuroxime ester
HUP9702472A3 (en)	2000-06-28	Process for producing allyl-amine derivative and salts thereof
PL325602A1 (en)	1998-08-03	Alternative crystalline form of thazophenelone
HU9302114D0 (en)	1993-11-29	Method for producing thyramine derivatives
IL125283A0 (en)	1999-03-12	Process for the preparation of solvated crystalline forms of benzothiophene derivatives
HU9302156D0 (en)	1993-10-28	Method for producing 11beta-hydroxi-pregnane derivatives